8-K filed February 22, 2024, 6:59 PM ET ticker HCAT CIK 0001636422

earnings confidence high sentiment neutral materiality 0.60

Health Catalyst Q4 rev $75.1M (+9% YoY), FY rev $295.9M; CFO Hunt resigns, Alger named CFO; guides 2024 rev $304-312M

Health Catalyst, Inc.

2023-FY EPS reported -$2.09 revenue$295,938,000

Q4 total revenue $75.1M, up 9% YoY; net loss $30.3M; adjusted EBITDA $1.4M (in line with guidance midpoint).
FY2023 total revenue $295.9M, beat guidance midpoint; net loss $118.1M; adjusted EBITDA $11.0M (in line with guidance).
2024 guidance: revenue $304-312M; adjusted EBITDA $24-26M (~125%+ YoY growth at midpoint).
CFO Bryan Hunt resigns effective March 1, replaced by CAO Jason Alger; Dan LeSueur appointed COO effective same date.
Director Mark Templeton resigns effective March 1; 13,405 RSUs accelerated vesting; no disagreement cited.

item 2.02 item 9.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jason Alger

Chief Financial Officer

HCAT · Health Catalyst, Inc.

Effective: 2024-03-01
Filed: February 22, 2024, 6:59 PM ET

On February 22, 2024, the Company announced that Jason Alger, age 40, the Company’s Chief Accounting Officer and principal accounting officer, will assume the role of Chief Financial Officer and principal financial officer of the Company, effective March 1, 2024.

Departed

Bryan Hunt

Chief Financial Officer

HCAT · Health Catalyst, Inc.

Effective: 2024-03-01
Successor: Jason Alger
Filed: February 22, 2024, 6:59 PM ET

On February 16, 2024, Bryan Hunt informed the board of directors of the Company (the Board) of, and on February 20, 2024, the Board accepted, his resignation as the Company's Chief Financial Officer and principal financial officer, effective March 1, 2024.

Appointed

Daniel LeSueur

Chief Operating Officer

HCAT · Health Catalyst, Inc.

Effective: 2024-03-01
Filed: February 22, 2024, 6:59 PM ET

On February 22, 2024, the Company announced that Daniel LeSueur, age 45, the Company’s Senior Vice President and General Manager of the Professional Services Business Unit, will assume the role of Chief Operating Officer and principal operating officer of the Company, effective March 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Health Catalyst, Inc. updated its the quarter and year ended December 31, 2023 guidance (reaffirmed).

Period: the quarter and year ended December 31, 2023
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On February 22, 2024, Health Catalyst, Inc. (the Company) issued a press release relating to its financial results for the quarter and year ended December 31, 2023. A copy of the press release, the summary of the Company's 2023 Financial Highlights, 2024 Guidance & Key Themes, and the summary of the Company’s Updated Growth and Financial Targets are attached hereto as Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3, respectively, and each are incorporated herein by reference.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Alger was appointed as Chief Financial Officer at Health Catalyst, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On February 22, 2024, the Company announced that Jason Alger, age 40, the Company’s Chief Accounting Officer and principal accounting officer, will assume the role of Chief Financial Officer and principal financial officer of the Company, effective March 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Bryan Hunt resigned as Chief Financial Officer at Health Catalyst, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On February 16, 2024, Bryan Hunt informed the board of directors of the Company (the Board) of, and on February 20, 2024, the Board accepted, his resignation as the Company's Chief Financial Officer and principal financial officer, effective March 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel LeSueur was appointed as Chief Operating Officer at Health Catalyst, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On February 22, 2024, the Company announced that Daniel LeSueur, age 45, the Company’s Senior Vice President and General Manager of the Professional Services Business Unit, will assume the role of Chief Operating Officer and principal operating officer of the Company, effective March 1, 2024.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-24-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.